Table 2.
Parameter | Dose (mL) | CONTROL | UHCO | SHCO | 3RHCO |
---|---|---|---|---|---|
GLU (mg/dL) | 0.1 | 70.42 ± 5.87 | 70.93 ± 0.92 | 81.62 ± 1.77 | 86.30 ± 2.04 |
0.2 | 70.97 ± 0.71 | 82.09 ± 1.46 | 87.75 ± 1⋅71* | ||
CRE (mg/dL) | 0.1 | 0.98 ± 0.26 | 1.29 ± 0.17 | 1.35 ± 0.28 | 1.65 ± 0.62 |
0.2 | 1.31 ± 0.12 | 1.43 ± 0.26 | 1.71 ± 0.91* | ||
CHOL (mg/dL) | 0.1 | 143.06 ± 13.06 | 152.72 ± 13.64 | 165.63 ± 12.68 | 247.65 ± 14.81 |
0.2 | 159.14 ± 14.92 | 174.19 ± 13.60 | 249.99 ± 13.79* | ||
PRO (mg/dL) | 0.1 | 5.15 ± 0⋅42 | 5.09 ± 1.23 | 4.83 ± 0.53 | 3.76 ± 0.43* |
0.2 | 4.91 ± 1.32 | 4.77 ± 0.46 | 3.57 ± 0.42 | ||
ALB (mg/dL) | 0.1 | 4.21 ± 1⋅15 | 4.05 ± 1.12 | 2.95 ± 0.72 | 1.59 ± 0.70* |
0.2 | 3.08 ± 0.62 | 2.63 ± 0.75 | 1.52 ± 0.64 |
Data represented as mean ± S.D. Significantly different from control at *P < 0.05; n = 10 animals per group.